Teva- Pharmaceutical Industries Ltd vs Zoetis Inc

Teva- Pharmaceutical Industries Ltd (TEVA) is overvalued and Zoetis Inc (ZTS) is undervalued.

Against our estimates of intrinsic value, ZTS trades at the wider discount: a margin of safety of +27%, against -110% for TEVA.

Values as of the 17 Nov 2026 close.

Teva- Pharmaceutical Industries Ltd (TEVA)

Discounting its cash flows at 9.7% (average of 3 methods) values the shares at $20.28; the price of $42.62 is 110% above that value, and 73% of that value comes from beyond year five.

Leak Score: free with an account

Zoetis Inc (ZTS)

Discounting its cash flows at 8.1% (average of 3 methods) values the shares at $113.90; the price of $83.48 is 27% below that value, and 79% of that value comes from beyond year five.

Leak Score: free with an account

MetricTEVAZTS
VerdictOvervaluedUndervalued
Price$42.62$83.48
Intrinsic value$20.28$113.90
Margin of safety-110%+27%
Market cap$49.7B$33.9B
Revenue growth, 5 years0.8%7.2%
Operating margin19.2%37.4%
Net margin2.9%26.2%
Return on equity6.7%57.1%
Debt to equity2.132.80
P/E100.3x14.2x
Forward P/E13.7x13.2x
P/B6.2x10.3x
Dividend yield—2.5%

All stocks in Drug Manufacturers - Specialty & Generic